| Assessment of response to systemic therapy focusing on metastatic bone disease. | |
| | |
MedLine Citation:
|
PMID: 11417968 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The 25-year-old rules for response evaluation developed by UICC and WHO still remain the cornerstone for response evaluation and documentation of treatment effects from systemic cancer treatment. Often, however, plain radiographs are insensitive to changes in tumour growth and disagree with clinical findings. Other methods of evaluation, such as biochemical markers and newer imaging technology may provide valuable additional information in these cases. |
| | |
Authors:
|
C Blomqvist |
Related Documents
:
|
23068708 - Locally recurrent prostate cancer after initial radiation therapy: early salvage high-i... 10773538 - 18f-labeled radiopharmaceuticals for pet in oncology, excluding fdg. 12458398 - Lean body mass-based standardized uptake value, derived from a predictive equation, mig... 12190138 - The superficial mandibular gland of the rabbit: a new experimental model for scintigrap... 3299078 - Effect of histamine h2-receptor antagonist therapy on the mutagenic activity of gastric... 17160068 - Health-related quality-of-life after external beam radiation therapy for localized pros... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Cancer treatment reviews Volume: 27 ISSN: 0305-7372 ISO Abbreviation: Cancer Treat. Rev. Publication Date: 2001 Jun |
Date Detail:
|
Created Date: 2001-06-21 Completed Date: 2001-07-05 Revised Date: 2009-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 7502030 Medline TA: Cancer Treat Rev Country: England |
Other Details:
|
Languages: eng Pagination: 177-80 Citation Subset: IM |
Copyright Information:
|
Copyright 2001 Harcourt Publishers Ltd. |
Affiliation:
|
Department of Radiotherapy and Oncology, Helsinki, Finland. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Biological Markers Bone Neoplasms / secondary*, therapy* Bone and Bones / radionuclide imaging Humans Magnetic Resonance Imaging Tomography, X-Ray Computed |
| Chemical | |
Reg. No./Substance:
|
0/Biological Markers |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Metastatic bone disease: clinical features, pathophysiology and treatment strategies.
Next Document: Bone markers in the management of metastatic bone disease.